Cite

HARVARD Citation

    Armand, P. et al. (2016). A phase 2 study of Rituximab‐Bendamustine and Rituximab‐Cytarabine for transplant‐eligible patients with mantle cell lymphoma. British journal of haematology. pp. 89-95. [Online]. 
  
Back to record